PRIMARY STUDY

CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature

Key Findings:  Resulting data showed that the administration of lower doses of CBD with trace amounts of THC appear to be a promising approach to manage behavioral problems associated with autism. More specifically, the authors report a decrease in behavioral problems (10 patients), an increase in expressive language (7 patients), improved cognition (4 patients), and an increase in social interaction (3 patients) for example.

Type of Study:  Clinical Trial

Study Sample Size:  33

Study Result:  Positive

Study Location(s):  Turkey

Year of Pub:  2021


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)

Phytocannabinoid Source:  Cannabis Flower derived

Chemotype:  Chemotype III

Dosage: CBD 0.3–2 mg/kg/day (with a maximum of 0.3% THC).

Route of Administration:  Oral (Ingestion)



Link to study